Revvity price to free cash flow RVTY

Market value divided by free cash flow over the last twelve months, since 2011.

Today, Oct 23, 2026: 31.7×
10-year median: 26.1×
Against its 10-year history: 65th; percentile: 0 is its lowest day, 100 its highest
10-year range: 12.6× to 157×
Peer median: 31.6×

Revvity's price to free cash flow is 31.7× as of Oct 23, 2026.

That is above its ten-year median of 26.1×, higher than on 65% of days in the last ten years.

Over that time it ranged from 12.6× in Jun 2021 to 157× in Aug 2024.

The median for 10 diagnostics and research stocks of a similar size is 31.6×.

Price to free cash flow over time

median 26.1×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	31.7×	18.4×	31.7×
2025	22.1×	19.1×	27.2×
2024	24.1×	23.6×	157×
2023	68.7×	20.2×	92.6×
2022	22.6×	14.1×	22.6×
2021	17.3×	12.6×	32.8×
2020	29.5×	26.6×	50.8×
2019	48.6×	40.8×	51.6×
2018	42.4×	28.6×	60.6×
2017	28.8×	18.9×	28.8×
2016	19.7×	18.9×	25.0×
2015	25.7×	20.8×	27.4×
2014	21.9×	20.8×	64.4×
2013	60.3×	23.0×	95.6×
2012	21.6×	15.3×	22.7×
2011	16.7×	14.6×	25.6×

Against its peers

Companies in Medical - Diagnostics & Research nearest Revvity's size, closest first, today.

Company	Price to free cash flow
RVTYRevvity	31.7×
MEDPMedpace	26.4×
LHLabcorp	23.1×
DGXQuest Diagnostics	19.8×
BIOBio-Rad Laboratories	28.0×
MTDMettler-Toledo International	38.7×
CAICaris Life Sciences	73.0×
ILMNIllumina	43.7×
IDXXIDEXX Laboratories	35.2×
WATWaters	112×
IQVIQVIA	21.1×
Peer median	31.6×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Revvity

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.